Carbopol® 940 Hydrogel Functionalised with Plasma-Activated Water: An Advanced Platform for Diabetic Foot Ulcer Management
Summary: This study evaluated a Carbopol 940 hydrogel enriched with plasma-activated water (PAW). In a clinical case of a recalcitrant Wagner Grade 2 diabetic foot ulcer, the hydrogel applied as monotherapy (without systemic antibiotics) achieved complete healing. The platform combines antimicrobial properties with a supportive moist environment, showing strong potential for advanced wound care.
Key Highlights:
- Successful monotherapy healing of hard-to-heal Wagner Grade 2 DFU
- Strong antimicrobial and pro-regenerative effects from PAW
- Promising advanced hydrogel platform for infected/chronic wounds
- Potential to reduce reliance on systemic antibiotics
Keywords: plasma activated water DFU, Carbopol hydrogel, advanced DFU hydrogel